Longitudinal Analysis of Real-World Performance of an Implantable Continuous Glucose Sensor over Multiple Sensor Insertion and Removal Cycles

The Eversense(®) Continuous Glucose Monitoring (CGM) System, with the first long-term, implantable glucose sensor, has been commercially available in Europe and South Africa since 2016 for adults with diabetes. The performance of the sensor over multiple, sequential 90- or 180-day cycles from either...

Descripción completa

Detalles Bibliográficos
Autores principales: Tweden, Katherine S., Deiss, Dorothee, Rastogi, Ravi, Addaguduru, Suresh, Kaufman, Francine R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196365/
https://www.ncbi.nlm.nih.gov/pubmed/31697182
http://dx.doi.org/10.1089/dia.2019.0342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196365/
https://www.ncbi.nlm.nih.gov/pubmed/31697182
http://dx.doi.org/10.1089/dia.2019.0342

Ejemplares similares